PMID- 12702049 OWN - NLM STAT- MEDLINE DCOM- 20031002 LR - 20210712 IS - 0815-9319 (Print) IS - 0815-9319 (Linking) VI - 18 IP - 5 DP - 2003 May TI - Enhanced intestinal inflammation induced by dextran sulfate sodium in tumor necrosis factor-alpha deficient mice. PG - 560-9 AB - BACKGROUND AND AIMS: Tumor necrosis factor-alpha (TNF-alpha) is a potent pro-inflammatory cytokine thought to be involved in the pathogenesis of inflammatory bowel disease. To further define the role of TNF-alpha in intestinal inflammation, we studied the effects of dextran sulfate sodium (DSS) administration in mice with targeted deletions of TNF-alpha gene. METHODS: Acute colitis was induced in female TNF-alpha-/- and TNF-alpha+/+ mice by administering 4.5% DSS orally in drinking water for seven days. The colonic mucosal injury and inflammation was evaluated based on body weight changes, total colon length, luminal hemoglobin, and histological findings. Colonic mRNA expression for inducible nitric oxide synthase (iNOS), TNF-alpha, interferon-gamma (IFN-gamma) and interleukin-4 (IL-4) were measured by reverse transcription polymerase chain reaction (RT-PCR), and nuclear factor kappaB (NF-kappaB) activation was evaluated by electrophoretic mobility shift assay. RESULTS: In each assessment, colonic injury was significantly aggravated in DSS-treated TNF-alpha-/- mice compared with DSS-treated TNF-alpha+/+ mice. The survival rate of TNF-alpha-/- mice on day seven was 40%; in contrast, all TNF-alpha+/+ mice were alive. Histological study also showed an enhanced infiltration of inflammatory cells, especially neutrophils, and mucosal cell disruption in DSS-treated TNF-alpha-/- mice compared with DSS-treated TNF-alpha+/+ mice. On day seven, mRNA levels of IFN-gamma and IL-4 in the colons of TNF-alpha-/- mice were faint or not detected; in contrast, those of TNF-alpha+/+ mice were detected. Although the expression of iNOS mRNA and luminal nitrite levels were similarly increased in both mice on day seven, this induction was delayed in TNF-alpha-/- mice during the early phase. The degree of NF-kappaB binding activity seemed to be similar between the two types of mice on day seven. CONCLUSION: DSS-induced inflammation is significantly enhanced in TNF-alpha-/- mice compared to TNF-alpha+/+ mice. These data suggest that persistent and marked blockage of TNF-alpha bioactivity may provide a detrimental effect on acute intestinal inflammation. CI - Copyright 2003 Blackwell Publishing Asia Pty Ltd FAU - Naito, Yuji AU - Naito Y AD - First Department of Medicine, Kyoto Prefectural University of Medicine, Kamigyo-Ku, Kyoto, Japan. ynaito@koto.kpu-m.ac.jp FAU - Takagi, Tomohisa AU - Takagi T FAU - Handa, Osamu AU - Handa O FAU - Ishikawa, Takeshi AU - Ishikawa T FAU - Nakagawa, Shuji AU - Nakagawa S FAU - Yamaguchi, Taiji AU - Yamaguchi T FAU - Yoshida, Norimasa AU - Yoshida N FAU - Minami, Masato AU - Minami M FAU - Kita, Masakazu AU - Kita M FAU - Imanishi, Jiro AU - Imanishi J FAU - Yoshikawa, Toshikazu AU - Yoshikawa T LA - eng PT - Comparative Study PT - Journal Article PL - Australia TA - J Gastroenterol Hepatol JT - Journal of gastroenterology and hepatology JID - 8607909 RN - 0 (Cytokines) RN - 0 (RNA, Messenger) RN - 0 (Tumor Necrosis Factor-alpha) RN - 9042-14-2 (Dextran Sulfate) RN - EC 1.14.13.39 (Nitric Oxide Synthase) RN - EC 1.14.13.39 (Nitric Oxide Synthase Type II) RN - EC 1.14.13.39 (Nos2 protein, mouse) SB - IM MH - Acute Disease MH - Animals MH - Colitis/*chemically induced/metabolism/pathology MH - Cytokines/genetics/metabolism MH - Dextran Sulfate/*toxicity MH - Female MH - Intestinal Mucosa/metabolism/pathology MH - Male MH - Mice MH - Mice, Inbred C57BL MH - Mice, Knockout MH - Nitric Oxide Synthase/genetics/metabolism MH - Nitric Oxide Synthase Type II MH - RNA, Messenger/analysis MH - Reverse Transcriptase Polymerase Chain Reaction MH - Tumor Necrosis Factor-alpha/deficiency/*physiology EDAT- 2003/04/19 05:00 MHDA- 2003/10/03 05:00 CRDT- 2003/04/19 05:00 PHST- 2003/04/19 05:00 [pubmed] PHST- 2003/10/03 05:00 [medline] PHST- 2003/04/19 05:00 [entrez] AID - 3034 [pii] AID - 10.1046/j.1440-1746.2003.03034.x [doi] PST - ppublish SO - J Gastroenterol Hepatol. 2003 May;18(5):560-9. doi: 10.1046/j.1440-1746.2003.03034.x.